Boreal Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Boreal Capital Management's XBI Position: Q1 2026 in Review
Boreal Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 33% in Q1 2026, buying an estimated $20K and bringing the position to 642 shares worth $82K. The position accounts for 0.07% of the portfolio, ranked #162.
Boreal Capital Management first reported a position in XBI in Q3 2025 and has held it in 3 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Boreal Capital Management held 642 shares of State Street SPDR S&P Biotech ETF worth $82K as of Q1 2026.
- Boreal Capital Management bought 160 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $20K.
- State Street SPDR S&P Biotech ETF made up 0.07% of Boreal Capital Management's portfolio in Q1 2026, its #162 holding.
- Boreal Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2025 and has held it in 3 quarters since.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Boreal Capital Management's 13F filing for Q1 2026, filed 14 May 2026.